Sg3 Management, LLC Theravance Biopharma, Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $208,568 - $256,432	-24,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $206,584 - $321,408	24,800 New	24,800 $237,000
Q2 2021 Aug 16, 2021	SELL	$14.52 - $22.46 $188,760 - $291,980	-13,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $215,410 - $274,040	13,000 New	13,000 $265,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.